These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23477730)

  • 21. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
    Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
    Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A novel immunization strategy to induce strong humoral responses against HIV-1 using combined DNA, recombinant vaccinia virus and protein vaccines].
    Liu C; Wang SH; Ren L; Hao YL; Zhang QC; Liu Y
    Bing Du Xue Bao; 2014 Nov; 30(6):645-51. PubMed ID: 25868279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
    Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015.
    Weniger BG; Anglin IE; Tong T; Pensiero M; Pullen JK;
    Vaccine; 2018 Jan; 36(4):427-437. PubMed ID: 29174315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaches to preventative and therapeutic HIV vaccines.
    Gray GE; Laher F; Lazarus E; Ensoli B; Corey L
    Curr Opin Virol; 2016 Apr; 17():104-109. PubMed ID: 26985884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime.
    Smith JM; Amara RR; Campbell D; Xu Y; Patel M; Sharma S; Butera ST; Ellenberger DL; Yi H; Chennareddi L; Herndon JG; Wyatt LS; Montefiori D; Moss B; McClure HM; Robinson HL
    AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1335-47. PubMed ID: 15650426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses.
    Hallengärd D; Applequist SE; Nyström S; Maltais AK; Marovich M; Moss B; Earl P; Nihlmark K; Wahren B; Bråve A
    Viral Immunol; 2012 Oct; 25(5):423-32. PubMed ID: 23035853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.
    Bråve A; Gudmundsdotter L; Sandström E; Haller BK; Hallengärd D; Maltais AK; King AD; Stout RR; Blomberg P; Höglund U; Hejdeman B; Biberfeld G; Wahren B
    Vaccine; 2010 Nov; 28(51):8203-9. PubMed ID: 20951666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses.
    Bolhassani A; Kardani K; Vahabpour R; Habibzadeh N; Aghasadeghi MR; Sadat SM; Agi E
    Immunol Lett; 2015 Dec; 168(2):366-73. PubMed ID: 26518142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity.
    Ajamian L; Melnychuk L; Jean-Pierre P; Zaharatos GJ
    Viruses; 2018 Feb; 10(3):. PubMed ID: 29495537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain.
    Lian Y; Srivastava I; Gómez-Román VR; Zur Megede J; Sun Y; Kan E; Hilt S; Engelbrecht S; Himathongkham S; Luciw PA; Otten G; Ulmer JB; Donnelly JJ; Rabussay D; Montefiori D; van Rensburg EJ; Barnett SW
    J Virol; 2005 Nov; 79(21):13338-49. PubMed ID: 16227256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation of HIV-1 subtype C vaccine constructs induced immune response in mice by CpG motif 1826-ODN.
    Aggarwal P; Pandey RM; Seth P
    Viral Immunol; 2005; 18(1):213-23. PubMed ID: 15802966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches for the design and evaluation of HIV-1 DNA vaccines.
    Calarota SA; Weiner DB
    Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S135-49. PubMed ID: 15285712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Huang X; Zhu Q; Huang X; Yang L; Song Y; Zhu P; Zhou P
    Vaccine; 2017 Apr; 35(16):2042-2051. PubMed ID: 28318765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
    Huang X; Liu L; Ren L; Qiu C; Wan Y; Xu J
    Vaccine; 2007 Dec; 25(52):8874-84. PubMed ID: 18061316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.
    Rosa DS; Ribeiro SP; Fonseca SG; Almeida RR; Santana VC; Apostólico Jde S; Kalil J; Cunha-Neto E
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1077-88. PubMed ID: 26149745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation.
    Vandermeulen G; Vanvarenberg K; De Beuckelaer A; De Koker S; Lambricht L; Uyttenhove C; Reschner A; Vanderplasschen A; Grooten J; Préat V
    Vaccine; 2015 Jun; 33(28):3179-85. PubMed ID: 25980430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization of neonatal mice with LAMP/p55 HIV gag DNA elicits robust immune responses that last to adulthood.
    Rigato PO; Maciel M; Goldoni AL; Piubelli O; de Brito CA; Fusaro AE; Eurico de Alencar LX; August T; Azevedo Marques ET; da Silva Duarte AJ; Sato MN
    Virology; 2010 Oct; 406(1):37-47. PubMed ID: 20667577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.